Oxalic Acid

Oxalic Acid

SCHEMBL6998475

CCCCCN1CC[C@H](CCOc2ccc([N+](=O)[O-])cc2)[C@@H](OC)C1.O=C(O)C(=O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.59
ALDH1A1 P00352 6/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
TDP1 Q9NUW8 3/20 0.56
KMT2A Q03164 2/20 0.56
MAPT P10636 3/20 0.48
HRH3 Q9Y5N1 3/20 0.47
HRH2 P25021 1/20 0.46
HRH1 P35367 1/20 0.46
GALR3 O60755 1/20 0.45
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL6988481 1.00 KDM4E (0.59) KDM4EALDH1A1SMN1; SMN2TDP1KMT2A
Oxalic Acid SCHEMBL6997995 0.87 RAB9A (0.53) KDM4EALDH1A1SMN1; SMN2TDP1KMT2A
Oxalic Acid SCHEMBL6991838 0.87 HRH3 (0.58) KMT2AHRH3
Oxalic Acid SCHEMBL6987195 0.87 RAB9A (0.53) KDM4EALDH1A1SMN1; SMN2TDP1KMT2A
Oxalic Acid SCHEMBL6994186 0.87 HRH3 (0.58) KMT2AHRH3
Oxalic Acid SCHEMBL7000093 0.86 HRH3 (0.58) KDM4EALDH1A1KMT2AHRH3HRH1
Oxalic Acid SCHEMBL6990281 0.86 HRH3 (0.58) KDM4EALDH1A1KMT2AHRH3HRH1
Oxalic Acid SCHEMBL7001883 0.86 HRH3 (0.48) KDM4EALDH1A1SMN1; SMN2KMT2AHRH3
Oxalic Acid SCHEMBL6996581 0.86 HRH3 (0.48) KDM4EALDH1A1SMN1; SMN2KMT2AHRH3
Oxalic Acid SCHEMBL6987245 0.85 KMT2A (0.60) KMT2AHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0853615-B1 PIPERIDINE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS NEUROSEARCH AS (DK) 2003-12-10 EP disclosed
US-5981539-A TREATMENT OF STROKE, ANOXIA, ISCHEMIA, MIGRAINE, PSYCHOSIS, EPILEPSY OR ANY OTHER CONVULSIVE DISORDER NEUROSEARCH A/S (DK) 1999-11-09 US disclosed